Get latest articles and stories on India at LatestLY. RSV poses a significant global public health challenge, particularly affecting children, and stands as the second most common cause of death in infants under one year of age, following only malaria. India News | AstraZeneca India Gets CDSCO Approval for 'Palivizumab' Preventive Therapy Against Respiratory Syncytial Virus.